Lumayaga, Carmie V.
HRN: 26-30-21 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/28/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
11/28/2024
12/04/2024
IV
2.25gm
Q6
Septicemia
Waiting Final Action
Indication: Empiric Type of Infection: PneumoniaBloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes